Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

Abstract Background Angiogenesis is essential for the progression and metastatic spread of solid tumours. Expression of vascular endothelial growth factor (VEGF) has been linked to poor survival among osteosarcoma patients but the clinical relevance of monitoring blood and urine angiogenic factors i...

Full description

Bibliographic Details
Main Authors: Marie-Dominique Tabone, Laurence Brugières, Sophie Piperno-Neumann, Marie-Ange Selva, Perrine Marec-Bérard, Hélène Pacquement, Cyril Lervat, Nadège Corradini, Jean-Claude Gentet, Rémy Couderc, Aurélie Chevance, Céline Mahier-Ait Oukhatar, Natacha Entz-Werle, Jean-Yves Blay, Marie-Cecile Le Deley
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Cancer
Subjects:
Osteosarcoma
Angiogenic factors
Vascular endothelial growth factor
Basic fibroblast growth factor
Online Access:http://link.springer.com/article/10.1186/s12885-017-3409-z

Internet

http://link.springer.com/article/10.1186/s12885-017-3409-z

Similar Items